WOUNDCHEK Bacterial Status and Protease Status Benefits Evaluation
Research type
Research Study
Full title
Clinical and Economic Effectiveness of Testing Chronic Wounds for BPA (bacterial protease activity) using WOUNDCHEK™ Bacterial Status and EPA (elevated host protease activity) using WOUNDCHEK™ Protease Status: A Pragmatic Randomised Clinical trial
IRAS ID
232299
Contact name
Kimberley Wilde
Contact email
Sponsor organisation
Woundchek Laboratories
Duration of Study in the UK
2 years, 0 months, 0 days
Research summary
This study aims to determine whether the use of Woundchek's Bacterial and Protease Status tests to inform future management in patients diagnosed with chronic ulcers which fail to heal, or which start to heal but the healing process then stalls with usual care, will improve healing rates. Its use in testing for elevated protease and bacterial protease and then managing appropriately could improve the health of patients and the use of resources as avoidance of unnecessary treatments,
less nursing time, fewer clinic visits for the patient and shorter overall treatment duration. There are currently no other comparative studies have been conducted so new knowledge could be gained.REC name
North West - Greater Manchester West Research Ethics Committee
REC reference
17/NW/0677
Date of REC Opinion
8 Dec 2017
REC opinion
Unfavourable Opinion